跳到主要內容區塊
:::

大腸直腸外科

Print
    吳志謙 WU Chih-Chien
    吳志謙 WU Chih-Chien
    看診科別
    現職
    • 高雄榮民總醫院大腸直腸外科 主治醫師
    • 國立陽明交通大學醫學系外科學科部定助理教授
    主治專長
    • 1.達文西機械手臂大腸直腸手術及腹腔鏡手術
    • 2.大腸鏡檢查及息肉切除治療
    • 3.肛門疾病手術治療(痔瘡、肛門膿瘍、廔管、肛裂等)
    • 4.大腸直腸疾病診斷及治療(血便、排便習慣改變、大型腸息肉、腸癌等)
    學歷
    • 國立陽明大學醫學士
    經歷
    • 高雄榮民總醫院外科住院醫師
    • 高雄榮民總醫院直腸外科總醫師
    • 高雄榮總屏東分院大腸直腸外科主治醫師
    • 韓國首爾延世大學大腸直腸癌微創手術進修
    • 英國倫敦聖馬克(St Mark's)醫院及附設學院達文西機械手臂手術進修
    代表著作
    • 1.Wu CC, Su CC, Chen YH, Hsu CW, Hsieh MC, Chang YC, Wang YC, Su YC. Comparative Effectiveness of Cetuximab Versus Panitumumab in Patients With Metastatic Colorectal Cancer: A Nationwide Database Study. Anticancer Res. 2023 Nov
    • 43(11):5127-5138.
    • 2.Wu CC, Hsu CW, Hsieh MC, et al. Optimal Sequence and Second-Line Systemic Treatment of Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Meta-Analysis. J Clin Med. 2021 Nov 4
    • 10(21):5166
    • 3.Chen YH, Su YC, Hsu CW, Hsieh MC, Wang YC, Lee MH, Lin CY, Chang YC, Wu CC*. Mortality of patients with metastatic colorectal cancer who received elective or emergent operation after exposure to bevacizumab: A nationwide database study. Eur J Surg Oncol. 2023 Feb
    • 49(2):445-451
    • 4.Wu CC, Wang JH, Lin PC, et al. Tumor sidedness and efficacy of first-line therapy in patients with RAS/BRAF wild-type metastatic colorectal cancer: A network meta-analysis. Crit Rev Oncol Hematol. 2020 Jan
    • 145:102823
    • 5.Wu CC, Wang JH, Chang MC, et al. Shared decision-making and patient decision aids in choosing first-line targeted therapy for metastatic colorectal cancer in Taiwan. J Oncol Pharm Pract. 2022 Sep
    • 28(6):1293-1302
    :::